Viral vector: potential therapeutic for glioblastoma multiforme

Area of Science:

• Neuro-oncology
• Molecular biology
• Gene therapy

Background:

• Glioblastoma multiforme is a highly malignant primary brain tumor in adults, representing the most aggressive form of glioma.
• Current treatments (chemotherapy, radiation, surgery) offer limited survival benefits, necessitating novel therapeutic strategies.
• Advancements in molecular biology highlight glioblastoma's unique characteristics, making it a candidate for gene therapy.

Purpose of the Study:

• To review the application of gene therapy for glioblastoma treatment.
• To explore the potential of viral vectors in delivering therapeutic genetic material to glioblastoma cells.

Main Methods:

• Literature review of existing research on gene therapy for glioblastoma.
• Analysis of viral vectors utilized for genetic material delivery in preclinical and clinical studies.
• Discussion of the mechanisms by which viruses can induce an anti-tumor response.

Main Results:

• Viruses possess inherent cytotoxic effects and are easily modifiable for therapeutic purposes.
• The horizontal transfer of genetic material by viruses makes them valuable tools for genetic engineering in cancer treatment.
• Various viral vectors have been identified and employed in experimental glioblastoma gene therapy.

Conclusions:

• Gene therapy, particularly using viral vectors, presents a promising frontier for overcoming the limitations of conventional glioblastoma treatments.
• Further research into optimizing viral vector design and delivery is crucial for clinical translation.
• Viral vectors offer a targeted approach to combat glioblastoma by inducing specific anti-tumor responses.